Phageguard Proceeds to the finals at Ideas from Europe

We are proud to announce that, after a great performance yesterday at the Ideas from Europe semi-finals in Tallinn, Phageguard was unanimously chosen by the jury to proceed to the finals. On top of this Phageguard was also chosen by the public to be the most innovative idea in Europe. The finals will take place in the Ridderzaal in The Hague on the 24th April.

We developed the world’s first targeted antibacterial products, set to replace antibiotics. This unlocks a completely new approach in dealing with the bacteria around us and enables preventive daily therapy against only unwanted bacteria for as long as needed.

Phageguard develops the world’s first targeted antibacterial products, set to replace antibiotics. With Phageguard endolysin technology, for the first time we can kill only the unwanted bacteria – including antibiotic resistant strains – while preserving the beneficial bacteria, essential for our health. In addition, scientists do not expect emergence of resistance against endolysins, based on their working mechanism. This unlocks a completely new approach in dealing with the bacteria around us – also enabling preventive daily therapy against only unwanted bacteria for as long as needed.

Phageguard has also developed FDA-approved food safety products against Salmonella and Listeria monocytogenes and is applied in many areas, including animal health and agriculture.

Phageguard is based in Wageningen ‘Food Valley’.